Niagen Bioscience Stock

Niagen Bioscience EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Niagen Bioscience (NAGE) as of Aug 14, 2026 is 14.30 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 7.73 M USD — a change of 85.04% (higher).

EBITDA

14.30 MUSD

YoY

85.04%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Niagen Bioscience is 2026 14.30 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Niagen Bioscience was 2025 7.73 M USD. It decreases by 85.04% higher compared to the previous year.
Access this data via the Eulerpool API

Niagen Bioscience Stock analysis

What does Niagen Bioscience do? The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Niagen Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Niagen Bioscience stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Niagen Bioscience is 14.30 M USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Niagen Bioscience changed from 7.73 M USD to 14.30 M USD, representing a 85.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Niagen Bioscience since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Niagen Bioscience historically and in real time.

Access this data via the Eulerpool API

Income Statement — Niagen Bioscience

All Key Metrics — Niagen Bioscience